Project Grant HT94252410926
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$294K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This Project Grant award of $999,996.00 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting research at the University of Illinois to investigate the mechanism governing the association between viral respiratory infection relapse and disease progression in persons with multiple sclerosis (MS). The research aims to transform health care for service members and the American public through innovative and impactful research, as...
The University of Illinois received a four-year, $2,068,139 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into exercise training programs to manage major depressive disorder symptoms experienced by individuals with multiple sclerosis. The University of Illinois will conduct this research from 2021 through 2025 in Chicago, Illinois. Through supporting innovative medical...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $799,496 project grant to the University of Illinois to conduct the research project "Environmental Disruption of Metabolism: Neurocognitive Consequences a Therapeutic Intervention". The award period runs from September 30, 2023 to September 29, 2025. The objective of this research is to investigate the neurocognitive impacts of environmental disruptions to metabolism and develop...
The University of Illinois has been awarded a $1,465,443 federal Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support advanced biomedical research focused on the "Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors" over a 3-year period from September 1, 2025 to August 31, 2028. The Military Medical Research and Development program provides funding for innovative medical...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...
This $284,659 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will fund research at the University of Illinois to investigate the "Regeneration of the Bone Marrow Hematopoietic Niche by Jagged1-Expressing Myeloid-Derived Suppressor Cells." The research, spanning from December 1, 2024 to November 30, 2026, aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...